Format

Send to

Choose Destination
See comment in PubMed Commons below
Breast Cancer Res. 2011;13(6):230. doi: 10.1186/bcr2923. Epub 2011 Dec 8.

'Omic approaches to preventing or managing metastatic breast cancer.

Author information

1
Lawrence Berkeley National Laboratory, Life Sciences Division, Cancer and DNA Damage Responses, One Cyclotron Road, Berkeley, CA 94720, USA.

Abstract

Early detection of metastasis-prone breast cancers and characterization of residual metastatic cancers are important in efforts to improve management of breast cancer. Applications of genome-scale molecular analysis technologies are making these complementary approaches possible by revealing molecular features uniquely associated with metastatic disease. Assays that reveal these molecular features will facilitate development of anatomic, histological and blood-based strategies that may enable detection prior to metastatic spread. Knowledge of these features also will guide development of therapeutic strategies that can be applied when metastatic disease burden is low, thereby increasing the probability of a curative response.

PMID:
22216753
PMCID:
PMC3326544
DOI:
10.1186/bcr2923
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Support Center